November 15, 2013, Newark, Ca., USA - StemCells, Inc., a life science company, announced that Greg Schiffman will join its executive team as chief financial officer and executive vice president of finance, effective January 1, 2014.<br /><br />Mr. Schiffman is a seasoned executive in the healthcare industry, with more than fifteen years of experience leading the financial operations and strategy of global publicly-traded companies such as Affymetrix and Applied Biosystems.<br /><br />Most recently, Mr. Schiffman was Executive Vice President and CFO of Dendreon Corporation since 2007.<br /><br />Before entering the healthcare field, Mr. Schiffman held roles of increasing responsibility within Hewlett Packard, where he served as controller of its European P.C. manufacturing and distribution operations in Grenoble, France, and as manufacturing manager and controller of its Netmetrix Division.<br /><br />Mr. Schiffman holds a bachelor's degree in accounting from De Paul University and an MBA from the Kellogg Graduate School of Management at Northwestern University. 